Why the study?
Does dobutamine prevent low cardiac output syndrome as effectively as milrinone in pediatric patients after cardiac surgery?
Does dobutamine prevent low cardiac output syndrome as effectively as milrinone in pediatric patients after cardiac surgery?
Dobutamine and milrinone are equally effective and safe for preventing low cardiac output syndrome after pediatric cardiac surgery, though dobutamine may be more cost-effective for uncomplicated cases.
Supports interchangeable use based on cost or availability; confirms equivalence of dobutamine and milrinone for LCOS prevention in this RCT.
Dobutamine and milrinone are safe, well tolerated, and equally effective in prevention of low cardiac output syndrome after pediatric cardiac surgery. The hemodynamic response of the two drugs is comparable. In uncomplicated cases, a trend toward the more cost-saving dobutamine might be anticipated; however, milrinone demonstrated a trend toward higher efficacy in afterload reduction.
No takes yet. Share an insight, caveat, or question.
Cavigelli-Brunner et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: